|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Short-term investments | |||||||||
| Accounts receivable (including related party amounts of $569 and $569, respectively) | |||||||||
| Other receivables (including related party amounts of $0 and $61, respectively) | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Restricted cash | |||||||||
| Property and equipment, net | |||||||||
| Operating lease right-of-use assets | |||||||||
| Financing lease right-of-use asset | |||||||||
| Long-term investments | |||||||||
| Deferred offering costs | |||||||||
| Other long-term assets | |||||||||
| Total assets | |||||||||
| Liabilities, convertible preferred stock, and stockholders' equity (deficit) | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Accrued expenses (including related party amounts of $22 and $0, respectively) | |||||||||
| Current portion of operating lease liabilities | |||||||||
| Current portion of financing lease liability | |||||||||
| Other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Operating lease liabilities, net of current portion | |||||||||
| Financing lease liability, net of current portion | |||||||||
| Simple agreements for future equity ("SAFEs") (including related party amounts of $0 and $20,315, respectively) | |||||||||
| Other non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Convertible preferred stock | |||||||||
| Series A convertible preferred stock | |||||||||
| Series B convertible preferred stock | |||||||||
| Stockholders' equity : | |||||||||
| Common stock, $0.0001 par value; 700,000,000 shares authorized at June 30, 2026 and December 31, 2025; 48,792,279 and 24,595,550 shares issued and outstanding at June 30, 2026 and December 31, 2025 respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive (loss) income | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
